ATLINKS (08043) released its interim results, with a profit attributable to shareholders of 12,100, a year-on-year decrease of 70.26%.

01:35 29/08/2026

ATLINKS (08043) released its interim results for the six months ended June 30, 2026, reporting revenue of 11.0529 million, a year-on-year decrease of 14.73%; profit attributable to equity holders of the company was 1.21 million, a year-on-year decrease of 70.26%; earnings per share were 0.

ATLINKS (08043) released its interim results for the six months ending June 30, 2026, with the group achieving revenue of 11.0529 million, a decrease of 14.73% year-on-year; the profit attributable to equity holders of the company was 1.21 million, down 70.26% year-on-year; earnings per share were 0.00.

After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).

After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).